The briefing
Researchers developed a breast cancer classification system designed to forecast which patients will respond to immune checkpoint inhibitors. The approach could improve treatment selection, as many patients currently do not benefit from ICIs.
Original headline
New breast cancer classification system predicts immunotherapy response success